# ZYDUSWELL (ZYDUSWELL) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/zyduswell

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹523.1
- Change: -4.22%
- As of: 2026-09-18
- 1D return: -4.38%
- 5D return: -7.78%
- 1M return: +4.18%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of September 18, 2026, ZYDUSWELL is trading at ₹522.25, with a technical stance that shows mixed signals across different timeframes. Daily indicators suggest a weakening trend, with the price below key moving averages like the 20-day EMA (₹539.9) and 50-day SMA (₹544.56), though the Supertrend indicator remains bullish. In contrast, weekly and monthly timeframes exhibit stronger bullish trends, with prices above their respective moving averages and Supertrend indicators. Recent formations include an active "Evening Star" and "Outside Bar" on the daily chart, indicating potential short-term caution.

The stock is currently positioned below several resistance levels, with the nearest at ₹535.48 (2.53% away) and ₹537.59 (2.94% away). Key support is observed further down at ₹477.1 (8.65% away). The stock has experienced recent volatility, including a high-severity "volume with price move" anomaly on September 7, 2026, and a "wide intraday range" anomaly on September 18, 2026. The annualized volatility stands at 36%, with a current drawdown of -13%. This suggests a risk environment where price fluctuations are notable.

- Current price: ₹522.25 as of September 18, 2026.
- Nearest resistance levels: ₹535.48 and ₹537.59.
- Nearest support level: ₹477.1.
- Daily timeframe shows price below key moving averages (20-day EMA, 50-day SMA), while weekly and monthly timeframes remain bullish.
- Active daily chart patterns include "Evening Star" and "Outside Bar" as of September 18, 2026.
- Annualized volatility is 36% with a current drawdown of -13%.

- Evening Star
- Outside Bar
- Bearish Engulfing Reversal
- Inside Bar
- Doji

### News Context

Zydus Wellness Limited has been the subject of exchange notices regarding significant trading volume increases. On September 8, 2026, the company submitted a response to the NSE concerning a notable spurt in volume, following a similar notice on September 7, 2026, where a response was awaited. Earlier in the week, on September 3, 2026, the company informed the exchange about an ESG rating assigned by SES. Additionally, on September 2, 2026, Zydus Wellness shared the transcript of its 32nd Annual General Meeting. A change in Directors/KMP/SMP/Auditor/RTA was also reported on September 1, 2026.

Technically, as of September 18, 2026, the stock's daily trend indicates a bullish Supertrend at 512.56, though the closing price of ₹522.25 is below the 20-day EMA of ₹539.9 and 50-day EMA of ₹536.74. The weekly trend also shows a bullish Supertrend at ₹460.79. Over the past six months, the stock has seen a return of 0.22, with a year-to-date return of 0.12. The nearest resistance levels are noted around ₹535.48 to ₹543.02, while support is identified around ₹477.1.

- On September 8, 2026, Zydus Wellness Limited provided its response to the NSE regarding a significant increase in trading volume.
- The company disclosed an ESG rating from SES on September 3, 2026.
- Zydus Wellness shared the transcript of its 32nd Annual General Meeting on September 2, 2026.
- A change in Directors/KMP/SMP/Auditor/RTA was reported on September 1, 2026.
- As of September 18, 2026, the daily trend shows a bullish Supertrend at ₹512.56, with nearest resistance observed between ₹535.48 and ₹543.02.

- Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has submitted their response. |SUBJECT: Spurt in Volume
- Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |SUBJECT: Spurt in Volume
- Zydus Wellness Limited has informed the Exchange about ESG rating assigned by SES |SUBJECT: General Updates
- Zydus Wellness Limited has informed the Exchange about Transcript of 32nd Annual General Meeting |SUBJECT: General Updates
- ZYDUS WELLNESS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA

### What Changed

Zydus Wellness, trading on the NSE, has experienced a recent price decrease. On September 18, 2026, the stock closed at ₹522.25, down from its previous closing price of ₹546.15 on an unspecified earlier date. No new filings or news developments were reported as of September 18, 2026. The company's profile and trading exchange remain unchanged.

- On September 18, 2026, Zydus Wellness's stock closed at ₹522.25.
- The previous closing price was ₹546.15.
- No new filings or news were reported as of September 18, 2026.

### Official Filings

Zydus Wellness Limited has provided updates on several fronts. The company reported its financial results for the first quarter of fiscal year 2027 (Q1 FY2027) on August 10, 2026. Net sales increased by 66.7% year-on-year to ₹14,299 million, attributed to the inclusion of the Comfort Click business and strong performance in premium product segments. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) rose by 55.3% to ₹2,417 million. However, net profit saw a 7% decrease, which the company explained was due to amortization costs related to acquired brands. Excluding these costs, net profit would have grown by 26.5%. The company also noted a 12% decline in seasonal brands like Nycil and Glucon-D due to adverse weather conditions in certain regions, while its international business grew by 24.8% on a like-to-like basis.

In management changes, Zydus Wellness announced the appointment of Mr. Kapil Sharma as Chief Revenue Officer on September 1, 2026. Separately, the company has been subject to exchange queries regarding a significant increase in trading volume. On September 7, 2026, the exchange noted this volume increase and was awaiting the company's response. Zydus Wellness submitted its response on September 8, 2026. The company also disclosed its ESG rating assigned by SES on September 3, 2026, and provided a transcript of its 32nd Annual General Meeting on September 2, 2026.

- On August 10, 2026, Zydus Wellness reported Q1 FY2027 consolidated net sales of ₹14,299 million, a 66.7% year-on-year increase.
- Q1 FY2027 EBITDA was ₹2,417 million, up 55.3% year-on-year.
- Net profit for Q1 FY2027 declined 7% year-on-year, attributed to amortization of acquired brands.
- On September 1, 2026, Mr. Kapil Sharma was appointed as Chief Revenue Officer.
- On September 8, 2026, the company submitted a response to the exchange regarding a significant increase in trading volume observed on September 7, 2026.

- Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has submitted their response. |SUBJECT: Spurt in Volume
- Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |SUBJECT: Spurt in Volume
- Zydus Wellness Limited has informed the Exchange about ESG rating assigned by SES |SUBJECT: General Updates
- Zydus Wellness Limited has informed the Exchange about Transcript of 32nd Annual General Meeting |SUBJECT: General Updates
- ZYDUS WELLNESS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
- Zydus Wellness Limited has informed the Exchange about appointment of Mr. Kapil Sharma as Chief Revenue Officer forming part of Senior Management of the Company |SUBJECT: Change in Management
- ZYDUSWELL|ZYDUS WELLNESS LIMITED|Original|Regulation 7 (2)|IT_2952_WebXMLFile_20260824_215350202.xml|IT_2952_20260824_215350235_WEB.html|5143|22247|-
- Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under SEBI (PIT) Regulations, 2015'. |SUBJECT: Updates
- Zydus Wellness Limited has informed the Exchange about Credit Rating |SUBJECT: Credit Rating
- Zydus Wellness Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates

### Fundamentals

Zydus Wellness reported a notable shift in its profitability trajectory across the observed periods. Revenue from operations showed variability, with ₹964.90 crore in Q3 FY2025-26, increasing to ₹1,484.70 crore in Q4 FY2025-26, before slightly declining to ₹1,437 crore in Q1 FY2026-27. The company moved from a loss before tax of -₹41.50 crore in Q3 FY2025-26 to a profit of ₹177.30 crore in Q4 FY2025-26, and then ₹162.10 crore in Q1 FY2026-27. This profitability improvement was accompanied by a decrease in finance costs, which fell from ₹41.20 crore in Q3 FY2025-26 to ₹26.30 crore in Q1 FY2026-27. The net profit for the period also reflected this trend, moving from a loss of -₹39.90 crore in Q3 FY2025-26 to a profit of ₹162 crore in Q4 FY2025-26 and ₹118.90 crore in Q1 FY2026-27. The tax expense varied, from -₹1.60 crore in Q3 FY2025-26 to ₹43.20 crore in Q1 FY2026-27.

Key monitoring areas for Zydus Wellness include the sustainability of its revenue growth, particularly the sequential trend observed between Q4 FY2025-26 and Q1 FY2026-27. Investors may also wish to track the company's ability to maintain profitability and manage its finance costs, given the significant swing from a loss to profit observed in the recent quarters.

- Revenue from operations was ₹964.90 crore in Q3 FY2025-26, ₹1,484.70 crore in Q4 FY2025-26, and ₹1,437 crore in Q1 FY2026-27.
- Profit Loss For Period was -₹39.90 crore in Q3 FY2025-26, ₹162 crore in Q4 FY2025-26, and ₹118.90 crore in Q1 FY2026-27.
- Profit Before Tax moved from -₹41.50 crore in Q3 FY2025-26 to ₹177.30 crore in Q4 FY2025-26 and ₹162.10 crore in Q1 FY2026-27.
- Finance Costs decreased from ₹41.20 crore in Q3 FY2025-26 to ₹26.30 crore in Q1 FY2026-27.
- Tax Expense was -₹1.60 crore in Q3 FY2025-26, ₹15.30 crore in Q4 FY2025-26, and ₹43.20 crore in Q1 FY2026-27.

### Bull Case

The company's stock shows strength across multiple timeframes, indicating a positive technical setup. On a daily basis, the Supertrend indicator is bullish, and the 20-day Exponential Moving Average (EMA) shows an upward slope. This trend is reinforced by weekly data, where the Supertrend is also bullish, and the 20-day EMA is rising. The monthly trend also displays a bullish Supertrend, suggesting sustained upward momentum. Recent performance shows a notable increase, with a 6-month return of 22% and a Year-to-Date (YTD) return of 12%.

- The daily Supertrend indicator is currently 'bullish'.
- The 6-month return as of the trade date was 22%.
- The Year-to-Date (YTD) return was 12% as of the trade date.
- The weekly Supertrend indicator is also 'bullish'.

### Bear Case

The company's stock is currently trading below its short-term moving averages, with the 20-day EMA at ₹539.9 and the 20-day SMA at ₹536.91, compared to the current close of ₹522.25. This suggests a potential short-term weakening in price momentum. Additionally, the stock has experienced a drawdown of 13% from its recent highs, indicating a period of price decline. The annualized volatility stands at 36%, and the Average True Range (ATR) as a percentage of the price is 3.61%, which may signal a higher degree of price fluctuation.

- The closing price of ₹522.25 is below the 20-day Exponential Moving Average (₹539.9) and the 20-day Simple Moving Average (₹536.91) as of 2026-09-18.
- The stock is experiencing a current drawdown of -13%.
- The annualized volatility is 36% as of 2026-09-18.
- The Average True Range (ATR) is 3.61% of the current price.

### FAQs

**What has been the recent trading volume activity for Zydus Wellness Limited?**

On September 7, 2026, the exchange noted a significant increase in Zydus Wellness Limited's trading volume and had written to the company for a response, which was still awaited. By September 8, 2026, the company had submitted its response regarding the volume spurt.

**What are Zydus Wellness Limited's recent technical indicators and price levels?**

As of September 18, 2026, Zydus Wellness Limited's closing price was ₹522.25. Daily technical indicators showed a 'bullish' Supertrend at 512.56. Monthly indicators also showed a 'bullish' Supertrend at 352.21. Nearest resistance levels were observed around ₹535.48 and ₹537.59, while the nearest support level was noted at ₹477.1.

**How has Zydus Wellness Limited performed over different periods?**

In the six months leading up to September 18, 2026, Zydus Wellness Limited returned 0.22. Year-to-date performance was 0.12, and since the start of trading, the return was 0.32. Over the last month, the stock returned 0.05, while the return over the last year was 0.0.

**What other recent announcements has Zydus Wellness Limited made?**

Zydus Wellness Limited informed the exchange about an ESG rating assigned by SES on September 3, 2026. Additionally, the company shared the transcript of its 32nd Annual General Meeting on September 2, 2026, and reported a change in Directors/KMP/SMP/Auditor/RTA on September 1, 2026.

- Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has submitted their response. |SUBJECT: Spurt in Volume
- Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |SUBJECT: Spurt in Volume
- Zydus Wellness Limited has informed the Exchange about ESG rating assigned by SES |SUBJECT: General Updates
- Zydus Wellness Limited has informed the Exchange about Transcript of 32nd Annual General Meeting |SUBJECT: General Updates
- ZYDUS WELLNESS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
## Technical analytics

- As of: 2026-09-18
- Daily trend: Moderate Downtrend
- Weekly trend: Weak Downtrend
- Pivot point: ₹547.62
- Risk regime: Price Risk Requires Attention

### Support levels
- 477.1
- 461.4
- 450.06874999999997

### Resistance levels
- 537.590625
- 543.025
- 552.7

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | -4.38% |
| return_10 | -2.96% |
| return_1m | +5.15% |
| return_1y | +0.26% |
| return_20 | +4.18% |
| return_3m | +3.49% |
| return_5 | -7.78% |
| return_6m | +21.64% |
| return_since_start | +32.14% |
| return_ytd | +12.49% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | elevated_risk |
| label | Price risk requires attention |
| summary | Recent drawdown or price variability is high enough to warrant closer monitoring. |
| maximum_drawdown | -28.76% |
| annualized_volatility | +35.72% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue grew sharply year-over-year, but higher taxes and finance costs reduced net profit

**Opening Summary**
Zydus Wellness reported ₹1,437 crore in revenue for the quarter ended 30 June 2026, a 66.92% increase from the same period last year. Sequentially, revenue dipped slightly by 3.21% from the preceding quarter’s ₹1,484.70 crore. Despite the larger top line, net profit fell to ₹118.90 crore from ₹127.90 crore a year ago. Pre-tax profit rose modestly to ₹162.10 crore, but a sharp rise in finance costs and a substantial increase in the tax charge absorbed the gains, compressing margins.

## Revenue Growth and Quarterly Pattern
Revenue reached ₹1,437 crore in the first quarter of FY2026-27. Compared to the year-ago quarter, this represents an increase of ₹576.10 crore. Sequentially, revenue decreased by ₹47.70 crore, or 3.21%, from the ₹1,484.70 crore recorded in the March quarter. Over the past five quarters, revenue moved from ₹860.90 crore in Q1 FY2025-26 to a low of ₹650.50 crore in the September quarter, before rising to ₹1,484.70 crore in December and settling near that peak in the current quarter.

## Profitability and Margin Movement
While revenue nearly doubled year-over-year, pre-tax profit grew by 11.56%, rising from ₹145.30 crore to ₹162.10 crore. This disparity indicates that the overall profitability per rupee of sales declined. The pre-tax profit margin contracted from 16.88% in the year-ago quarter to 11.28% in the current quarter. Similarly, the net profit margin fell from 14.86% to 8.27%. The business generated a larger revenue base, but a smaller portion of each rupee flowed through to the bottom line compared to the previous year.

## Finance Costs and Tax Expense
Finance costs were recorded at ₹26.30 crore for the quarter. This marks a significant increase of ₹23.80 crore compared to the ₹2.50 crore reported in the same quarter last year. In the context of a net profit of ₹118.90 crore, this additional cost represents a notable drag on earnings. However, finance costs have declined from their recent peaks of ₹41.20 crore in the September quarter and ₹38.70 crore in the December quarter, falling by 32.04% sequentially.

The most direct factor explaining the decline in net profit is the tax expense. The tax charge for the quarter was ₹43.20 crore, an increase of 148.28% from the ₹17.40 crore paid in the year-ago quarter. Pre-tax profit increased by ₹16.80 crore year-over-year, but the tax bill increased by ₹25.80 crore. Consequently, the net result was a reduction in profit after tax. The effective tax rate on pre-tax profit rose to 26.65% in the current quarter, compared to 11.97% in the prior year.

## Net Profit and Earnings Per Share
Net profit for the period stood at ₹118.90 crore. This marks a 7.04% decrease year-over-year and a 26.6% decrease from the ₹162 crore reported in the preceding quarter. The company returned to profitability after recording losses in the second and third quarters of FY2025-26.

Comprehensive income for the period was ₹107.90 crore, which is ₹11 crore below the net profit. This is the widest gap between the two measures across the five quarters shown, indicating that items recognized outside the income statement reduced total comprehensive income more significantly in this quarter than in previous periods.

Basic and diluted earnings per share from continuing operations were ₹3.74. This represents an 81.39% decline from the ₹20.10 reported a year ago. The drop in per-share earnings is far steeper than the 7.04% fall in net profit, despite the paid-up value of equity share capital remaining unchanged at ₹63.60 crore throughout the period. This divergence indicates a change in the number of shares used in the per-share calculation.

## Key Takeaway
The quarter demonstrated that a large increase in revenue did not lead to higher net profit. Zydus Wellness achieved a 66.92% increase in revenue year-over-year, yet net profit fell by 7.04%. Sharply higher finance costs and a more than doubling of the tax expense absorbed the gains from the larger revenue base, resulting in thinner margins and a lower bottom line.

### Ratios

## Official filings

- 2026-09-18 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_18092026180033_SEintimationSMP.pdf)
- 2026-09-18 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_2952_WebXMLFile_20260918_180547820.xml)
- 2026-09-18 — Management Change: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_ROID_98593_KMP_Doc.zip)
- 2026-09-08 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_08092026104543_SENSEintimationreplyvolumeincrease.pdf)
- 2026-09-07 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/content/RSS/Online_announcements.xml)
- 2026-09-03 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03092026163521_SEIntimationSESESGScore.pdf)
- 2026-09-02 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_02092026165036_SEintimationTranscript2026.pdf)
- 2026-09-01 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_2952_WebXMLFile_20260901_095432991.xml)
- 2026-09-01 — Management Change: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_01092026094207_SEintimationSMP.pdf)
- 2026-08-24 — Official Filing: ZYDUS WELLNESS LIMITED — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/IT_2952_WebXMLFile_20260824_215350202.xml)
- 2026-08-24 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_24082026215143_SEintimation.pdf)
- 2026-08-19 — Credit Rating Update: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_19082026182215_SEIntimationCAREcreditrating.pdf)
- 2026-08-10 — Earnings Presentation: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_10082026111145_SEintimationtranscript.pdf)
- 2026-08-08 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2952_WebXMLFile_20260808_163915106.xml)
- 2026-08-08 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_08082026183528_SEIntimationCRISILESGScore.pdf)
- 2026-08-08 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_08082026100427_SEIntimationInvestorconf08082026.pdf)
- 2026-08-05 — Generic Announcement: Zydus Wellness Limited published its unaudited consolidated financial results for the quarter ended June 30, 2026. Total income was 14,408 million, and net profit after tax was 1,189 million. These results were published in the Financial Express on August 5, 2026, following board approval on August 4, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_05082026221851_SEintimationad.pdf)
- 2026-08-04 — Management Change: Shareholders approved the appointment of Mr. Apurva S. Diwanji as an Independent Director of Zydus Wellness Limited for a five-year term from May 18, 2026, to May 17, 2031. The appointment was effective following a Board resolution on May 18, 2026, and shareholder approval at the 32nd Annual General Meeting on August 4, 2026. Mr. Diwanji is not related to any existing Director and is not debarred from holding such office. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04082026190617_SEintimationApptofDirector.pdf)
- 2026-08-04 — Earnings Presentation: Zydus Wellness Limited has released its investor presentation for the quarter ended June 30, 2026, detailing financial performance and business highlights. The company reported a 66.7% year-over-year increase in Net Sales to INR 14,299 million, with Revenue from Operations growing by 66.9% to INR 14,370 million. Gross Contribution saw a 99.5% increase to INR 9,436 million, representing 65.5% of net sales. EBITDA increased by 55.3% to INR 2,417 million, though the EBITDA Margin decreased to 16.8% from 18.1% in the prior year period. Profit After Tax (PAT) decreased by 7.0% to INR 1,189 million, with PAT Margin at 8.3%. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04082026122656_SEintimationInvestorPresentation.pdf)
- 2026-08-04 — Press Release: Zydus Wellness Limited reported unaudited financial results for the quarter ended June 30, 2026, with net sales increasing by 66.7% to ₹14,299 million compared to the previous year. EBITDA grew by 55.3% to ₹2,417 million, and net profit was ₹1,189 million. The company highlighted market leadership for brands like Sugar Free, Glucon-D, RiteBite Max Protein, Everyuth, and Nycil, and introduced new products including Complan Power Play and VieMax Diabetes Care. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04082026123126_SEintimationPressRelease.pdf)
- 2026-08-04 — Generic Announcement: On August 4, 2026, Zydus Wellness Limited's Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026. The company reported total revenue from operations of ₹1,530 million for the standalone entity and ₹14,370 million for the consolidated group for the quarter. The trading window for designated persons will remain closed until August 6, 2026. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04082026121715_SEintimationOutcomeofBM.pdf)
- 2026-08-04 — Generic Announcement: Zydus Wellness Limited held its Thirty Second Annual General Meeting on August 4, 2026, through video conferencing. All resolutions presented, including the adoption of financial statements, declaration of a ₹1.20 per share dividend, re-appointment of Dr. Sharvil P. Patel as Non-Executive Director, appointment of Mr. Apurva S. Diwanji as Independent Director, and ratification of Cost Auditors' remuneration, were passed with the requisite majority based on consolidated e-voting results. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04082026185849_SEintimationAGM.pdf)
- 2026-08-04 — Generic Announcement: Zydus Wellness Limited has made available the audio recording of its investor call concerning the unaudited financial results for the quarter ended June 30, 2026. The recording is accessible on the company's website via a provided link, in compliance with SEBI regulations. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04082026191752_SEintimationAudiorecording.pdf)
- 2026-08-04 — Official Filing: Zydus Wellness Limited appointed Mr. Apurva S. Diwanji as a Non-Executive Independent Director on August 4, 2026. Mr. Diwanji has over 32 years of experience specializing in mergers and acquisitions, private equity, and joint ventures, and is not related to any existing directors of the company.
- 2026-08-01 — Generic Announcement: Zydus Wellness Limited announced a special window for re-lodgement of transfer requests and dematerialization of physical securities, effective from February 5, 2026, to February 4, 2027. This initiative, in line with SEBI Circular No. HO/313/1(2)/2026-MIRSD.POD/1/3750 of 2026 dated January 30, 2026, aims to facilitate transfers and dematerialization for securities purchased before April 1, 2019. Investors must submit required documents to the Registrar and Share Transfer Agent, MUFG Investor Services India Private Limited, by February 4, 2027. — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_01082026232817_SEintimationad.pdf)

## News and market events

- 2026-09-07 — CNBC-TV18: **Zydus Wellness up 8%, PVR Inox down 7%: Check out other Nifty 500 top movers** — Some Nifty 500 stocks rallied at market open, while others slid on an executive exit report and profit booking — here's a look at today's top gainers and losers. — [Source](https://www.cnbctv18.com/market/stocks/zydus-wellness-up-8-pvr-inox-down-7-check-out-other-nifty-500-top-movers-19985230.htm)
- 2026-09-07 — Mint: **Volume shocker stocks today: Why Innovassynth, RIR Power, Pashupati Cotspin, Zydus Wellness are soaring - Data details h** — Volume shocker stocks today: Stocks such as Innovassynth, RIR Power, Pashupati Cotspin, and Zydus Wellness surged in morning deals on Monday, 7 September, amid a spurt in volume. — [Source](https://www.livemint.com/market/stock-market-news/volume-shocker-stocks-today-why-innovassynth-rir-power-pashupati-cotspin-zydus-wellness-are-soaring-data-details-h-11788753849711.html)
- 2026-09-04 — Times of India: **As protein demand rises, brands go for smaller packs** — India Business News: Mumbai: Protein foods are now a common sight across retail shelves, but consumers may increasingly also have the choice to go for smaller-sized portio. — [Source](https://timesofindia.indiatimes.com/business/india-business/as-protein-demand-rises-brands-go-for-smaller-packs/articleshow/133780266.cms)
- 2026-08-26 — Mint: **Raja Venkatraman recommends three stocks for 26 August** — Market expert Raja Venkatraman shares his top stock picks for 26 August. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-recommends-three-stocks-for-26-august-11787669841800.html)
- 2026-08-04 — The Hindu: **Q1 Results Today Live: Wonderla Holidays, Morepen Lab, RITES, Bharat Seats Q1 PAT up y-o-y, Godrej Properties & Zydus Wellness con. PAT decline, Bharti Airtel, ONGC, Pidilite, Marico, Nykaa, Bharti Hexacom, NHPC, MCX, Kalyan Jewellers, Alembic to announce Q1 results** — Q1 Results Today, 4th August 2026 Live Updates: Follow businessline for more — [Source](https://www.thehindubusinessline.com/markets/q1-results-today-live-updates-bharti-airtel-ongc-pidilite-nykaa-marico-nhpc-mcx-godrej-properties-zydus-alembic-rites-kalyan-jewellers-uno-minda-tata-invest-united-breweries-results-04-august-2026/article71300717.ece)
- 2026-08-04 — CNBC-TV18: **Zydus Wellness slips 5% as Q1 profit falls 7%, margin pressure weighs** — Zydus Wellness posted a consolidated net profit of ₹119 crore for the June quarter, compared with ₹128 crore in the corresponding period last year. Revenue from operations surged 67% year-on-year to ₹1,437 crore from ₹860.9 crore. — [Source](https://www.cnbctv18.com/market/zydus-wellness-share-price-slips-q1-results-profit-falls-margin-ebitda-19961305.htm)
- 2026-08-04 — CNBC-TV18: **Sensex Today | Stock Market Live Updates: Nifty at 24,500; Dee Devpt, Godrej Prop shares fall on Q1 results** — Stock Market LIVE Updates: Today's session is not only the weekly options expiry session for the Nifty 50 contracts, but is also set to see supply of paper worth nearly ₹36,000 crore, which includes the mega LIC Offer for Sale (OFS). Earnings season is drawing to a close and therefore, companies are making a beeline to report numbers as well. Adding to that is the confusion surrounding the Closing Auction Session. Watch this space for all the LIVE stock market updates. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-banks-midcaps-lic-paytm-meesho-kalyan-arvind-bharti-bse-share-price-liveblog-19960944.htm)
- 2026-08-04 — CNBC-TV18: **Q1 Results LIVE Updates: Symphony shares gain post earnings; Godrej Properties management commentary strong** — Q1 Results LIVE Updates: Two Nifty 50 companies Bharti Airtel, ONGC and Ajmera Realty, Alembic Pharma, BSE, Bharti Hexacom, Castrol, Godrej Properties, Greaves Cotton, Kalyan Jewellers, Marico, MCX, Nykaa, Metro Brands, NHPC, Motherson Sumi Wiring, Pidilite, Protean e-GOV, Keystone Realtors, RITES, Saregama, Safari Industries, Sanofi India, Tata Investment, Symphony, United Breweries, Uno Minda, VRL Logistics, Zydus Wellness, Welspun Enterprises, Wonderla Holidays, Prince Pipes, Metropolis Healthcare, CE InfoSystems, are among the other companies reporting their numbers today. Earnings reactions also come from stocks like DLF, IREDA, Torrent Power, and other such names. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-bharti-airtel-hexacom-ongc-dlf-sbi-funds-ireda-bse-mcx-kalyan-gcpl-marico-nykaa-pidilite-share-price-liveblog-19960965.htm)
- 2026-07-21 — Economic Times: **Qcomm leverages cart clout to draw higher margins from cos** — Quick commerce platforms are increasing demands for higher margins and marketing funds. Consumer goods companies face rising costs for better product visibility and keyword searches. These platforms are now adopting auction-style bidding for marketing activities. This shift pressures companies to invest more for prominent placement and sales. Reliance Retail is renegotiating terms by combining grocery stores and its quick commerce platform. — [Source](https://economictimes.indiatimes.com/industry/services/retail/qcomm-leverages-cart-clout-to-draw-higher-margins-from-cos/articleshow/132523471.cms)
- 2026-07-17 — Mint: **Raja Venkatraman recommends three stocks for 17 July | Stock Market News** — Market expert Raja Venkatraman shares his top stock picks for 17 July. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-recommends-three-stocks-for-17-july-11784248851294.html)

## Business profile

**Strategic vision:** Consumer wellness company with Indian heritage and global presence.

### Business segments
- **Food and Nutrition:** This segment includes a range of food and nutrition products designed to meet consumer health and dietary needs.
- **Dietary Supplements:** The company offers dietary supplements aimed at supporting health and wellness.
- **Pet Care:** This segment focuses on natural and safe food supplements for dogs and cats, primarily for European and US markets.
- **Skincare:** The company provides skincare products to address personal care needs.

### Competitive strengths
- Diverse portfolio of brands across multiple wellness segments.
- Extensive distribution channels including ground sales, business partners, and direct market access.
- Global operational footprint with manufacturing and co-manufacturing facilities.

## Related stocks

- [AWL (FMCG)](https://faxioms.com/stocks/awl) — +1.60%
- [BALRAMCHIN (FMCG)](https://faxioms.com/stocks/balramchin) — -0.35%
- [BRITANNIA (FMCG)](https://faxioms.com/stocks/britannia) — +0.36%
- [CCL (FMCG)](https://faxioms.com/stocks/ccl) — +0.24%
- [DABUR (FMCG)](https://faxioms.com/stocks/dabur) — +1.09%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/zyduswell
Markdown representation: https://faxioms.com/stocks/zyduswell?render=md